These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2871690)

  • 1. [Dynamics of the liberation of therapeutic substances from tablets. XXI. Comparison of 4 liberation models with Vasculat and Bupatol tablets as examples].
    Kasprzyk A; Pasich J
    Acta Pharm Hung; 1986 Mar; 56(2):49-53. PubMed ID: 2871690
    [No Abstract]   [Full Text] [Related]  

  • 2. [The dynamics of the drug release from tablets. Part 7: Comparison of three liberation models on Cholestil tablets (author's transl)].
    Pasich J; Niedworok E; Zajaç M
    Pharmazie; 1980 Dec; 35(12):778. PubMed ID: 7208581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dynamics of the liberation of drugs from tablets. II. Liberation of ascorbic acid].
    Pasich J; Lipiarz D
    Acta Pharm Hung; 1982 Jan; 52(1):10-4. PubMed ID: 7058687
    [No Abstract]   [Full Text] [Related]  

  • 4. [The liberation of phenylbutazone from tablets].
    Miseta M; Hoang Hun Manh ; Pintye-Hódi K; Szabó-Révész P; Selmeczi B
    Pharmazie; 1988 Oct; 43(10):697-8. PubMed ID: 3212016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The dynamics of the drug release from tablets. Part 6: Liberation of glaucine from Tussiglauzin Dragées (author's transl)].
    Pasich J; Niedworok E; Warzecha U
    Pharmazie; 1980 Dec; 35(12):777. PubMed ID: 7208580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effervescent aspartame tablets. II. The effect of granulometry and temperature on effervescence time and the kinetics and rate of carbon dioxide liberation].
    Joachim J; Kalantzis G; Delonca H; Sabatier R; Abramovici B; Lheritier J; Molard F
    J Pharm Belg; 1987; 42(5):303-14. PubMed ID: 3123639
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dependence of pill decomposition and liberation of active substances on pill mass and other factors].
    Bogs U; Därr A
    Pharmazie; 1973 Feb; 28(2):112-5. PubMed ID: 4687559
    [No Abstract]   [Full Text] [Related]  

  • 8. [Theory of the liberation of active ingredients by zero-order kinetics].
    Bozzay J; Dávid A; Rusznák I
    Acta Pharm Hung; 1980 Nov; 50(6):238-42. PubMed ID: 7270193
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. II. Evaluation of rabbits as qualitative animal model.
    Bansinath M; Ghosh SS; Shukla VK; Chopra KS; Mathur VS
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):303-7. PubMed ID: 3724304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination and interpretation of in vitro solubility behavior of pharmaceutical agents. 2. The effect of surface tension of the dissolution medium on the liberation of drugs in commercial preparations (tablets, dragees)].
    Bornschein M; Eitz K; Voigt R
    Pharmazie; 1987 Feb; 42(2):83-6. PubMed ID: 3602064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Doxycycline pellets: a suitable formulation with guaranteed bioequivalence].
    Hampel B; Lode H; Fenner H; Gikalov I
    Arzneimittelforschung; 1980; 30(11):1938-43. PubMed ID: 7193007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vivo testing of a 3-hydroxymethylpyridine hydrogen tartrate matrix tablet. Part 2: Comparison between the in vivo drug release from the matrix form and that from Radecol-tablets (author's transl)].
    Kala H; Danz R; Bekemeier H; Moldenhauer H
    Pharmazie; 1980; 35(4):216-21. PubMed ID: 7403243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Control of drug release from coated parenteral matrix-retard tablets using softening agents].
    Korsatko W; Wabnegg B
    Pharmazie; 1983 Sep; 38(9):608-11. PubMed ID: 6647533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Description of the process of in vitro liberation of matrix tablets].
    Appelt B; Kala H
    Pharmazie; 1986 Nov; 41(11):784-6. PubMed ID: 3562511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retard implantation tablets on a matrix base with Eudragit as a structural substance.
    Korsatko W
    Pharmazie; 1982 Apr; 37(4):272-3. PubMed ID: 7100251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of digoxin from tablets. I. In vitro characterization of digoxin tablets.
    Nyberg L; Bratt L; Forsgren A; Hugosson S
    Acta Pharm Suec; 1974 Nov; 11(5):447-58. PubMed ID: 4440503
    [No Abstract]   [Full Text] [Related]  

  • 17. [Power law equation and liberation kinetics].
    Zatloukal Z
    Ceska Slov Farm; 2005 Jan; 54(1):39-42. PubMed ID: 15751794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mathematical relationship of in vitro release rates and biological availability of controlled-release nitroglycerin (nitrong).
    Ipsen J
    Curr Ther Res Clin Exp; 1971 Mar; 13(3):193-208. PubMed ID: 4998572
    [No Abstract]   [Full Text] [Related]  

  • 19. Imaging of high-amylose starch tablets. 3. Initial diffusion and temperature effects.
    Thérien-Aubin H; Baille WE; Zhu XX; Marchessault RH
    Biomacromolecules; 2005; 6(6):3367-72. PubMed ID: 16283767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of HPLC, UV spectrophotometry and potentiometric titration methods for the determination of lumefantrine in pharmaceutical products.
    da Costa César I; Nogueira FH; Pianetti GA
    J Pharm Biomed Anal; 2008 Sep; 48(1):223-6. PubMed ID: 18571353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.